Endothelial Dysfunction and Amyloid-β-Induced Neurovascular Alterations
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Alzheimer’s disease (AD) and cerebrovascular diseases share common vascular risk factors that have disastrous effects on cerebrovascular regulation. Endothelial cells, lining inner walls of cerebral blood vessels, form a dynamic interface between the blood and the brain and are critical for the maintenance of neurovascular homeostasis. Accordingly, injury in endothelial cells is regarded as one of the earliest symptoms of impaired vasoregulatory mechanisms. Extracellular buildup of amyloid-β (Aβ) is a central pathogenic factor in AD. Aβ exerts potent detrimental effects on cerebral blood vessels and impairs endothelial structure and function. Recent evidence implicates vascular oxidative stress and activation of the non-selective cationic channel transient receptor potential melastatin (TRPM)-2 on endothelial cells in the mechanisms of Aβ-induced neurovascular dysfunction. Thus, Aβ triggers opening of TRPM2 channels in endothelial cells leading to intracellular Ca2+ overload and vasomotor dysfunction. The cerebrovascular dysfunction may contribute to AD pathogenesis by reducing the cerebral blood supply, leading to increased susceptibility to vascular insufficiency, and by promoting Aβ accumulation. The recent realization that vascular factors contribute to AD pathobiology suggests new targets for the prevention and treatment of this devastating disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structural and functional features of central nervous system lymphatic vessels
Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., Derecki, N. C., Castle, D., Mandell, J. W., Lee, K. S., et al. (2015) · Nature · doi:10.1038/nature14432 · Cited by 4,413
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280 · cited 13×
“…activity, is removed from the brain via mechanisms involving the lipoprotein receptor-related protein (LRP)-1 and P-glycoprotein, a mechanism regulated by the serum response factor, myocardin, and phosphatidylcholinebinding clathrin assembly protein (PICALM) (Zhao et al. 2015; Zlokovic 2008).”
InfluentialNeurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Glial and neuronal control of brain blood flow
Attwell, D., Buchan, A. M., Charpak, S., Lauritzen, M., MacVicar, B. A., & Newman, E. A. (2010) · Nature · doi:10.1038/nature09613 · Cited by 2,511 · cited 2×
“The brain is endowed with precise control mechanisms that ensure its energy supply well matched to its energetic needs (Iadecola 2004, 2013; Jackman and Iadecola 2015; Attwell et al. 2010; Lauritzen et al. 2012).”
Neurovascular regulation in the normal brain and in Alzheimer's disease
Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213
Immune attack: the role of inflammation in Alzheimer disease
Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3880 · Cited by 2,134 · cited 1×
“The expression of adhesion molecules, chemokines, and cytokines by endothelium, glia, and perivascular macrophages regulates the trafficking of immune cells across the BBB (Zlokovic 2008; Heppner et al. 2015).”
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics
Szabó, C., Ischiropoulos, H., & Radi, R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2222 · Cited by 2,134 · cited 1×
“Endothelial oxidative and nitrosative stress has emerged as key pathogenic factors in cerebrovascular dysfunction (Szabo et al. 2007; Iadecola 2004).”
Blood-brain barrier breakdown in the aging human hippocampus
Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078 · cited 1×
“Furthermore, impairments in Ab clearance through the BBB may also have an impact on the brain amyloid accumulation in AD (Taheri et al. 2011; Zlokovic 2008; Mawuenyega et al. 2010; Roberts et al. 2014).”
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,611
Alzheimer’s Disease: The Challenge of the Second Century
Holtzman, D. M., Morris, J. C., & Goate, A. M. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002369 · Cited by 1,424
Glial regulation of the cerebral microvasculature
Iadecola, C., & Nedergaard, M. (2007) · Nature Neuroscience · doi:10.1038/nn2003 · Cited by 1,153 · cited 3×
“These vascular effects have been attributed to Ab, a key pathogenic factor in AD, which potently constricts blood vessels and impairs the fundamental mechanisms controlling the cerebral circulation (Iadecola 2013; Iadecola et al. 1999; Thomas et al. 1996).”
Mfsd2a is critical for the formation and function of the blood-brain barrier
Ben-Zvi, A., Lacoste, B., Kur, E., Andreone, B. J., Mayshar, Y., Yan, H., & Gu, C. (2014) · Nature · doi:10.1038/nature13324 · Cited by 1,037
Age, Neuropathology, and Dementia
Savva, G. M., Wharton, S. B., Ince, P. G., Forster, G., Matthews, F. E., & Brayne, C. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806142 · Cited by 900 · cited 1×
“These alterations in angiogenesis are likely to have a powerful impact in the cerebrovascular alterations found in AD and vascular dementia as well as in the brain atrophy related to these diseases (Savva et al. 2009; Staekenborg et al. 2009).”
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
Drummond, G. R., Selemidis, S., Griendling, K. K., & Sobey, C. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3403 · Cited by 899 · cited 5×
“Initially identified in phagocytes, NADPH oxidase is also found in vascular cells and is especially abundant in the brain blood vessels (Drummond et al. 2011; Miller et al. 2005).”
InfluentialCerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study
Ruitenberg, A., den Heijer, T., Bakker, S. L. M., van Swieten, J. C., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2005) · Annals of Neurology · doi:10.1002/ana.20493 · Cited by 733
β-Amyloid-mediated vasoactivity and vascular endothelial damage
Thomas, T., Thomas, G., McLendon, C., Sutton, T., & Mullan, M. (1996) · Nature · doi:10.1038/380168a0 · Cited by 703 · cited 1×
“These vascular effects have been attributed to Ab, a key pathogenic factor in AD, which potently constricts blood vessels and impairs the fundamental mechanisms controlling the cerebral circulation (Iadecola 2013; Iadecola et al. 1999; Thomas et al. 1996).”
GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration
Winkler, E. A., Nishida, Y., Sagare, A. P., Rege, S. V., Bell, R. D., Perlmutter, D., Sengillo, J. D., Hillman, S., Kong, P., Nelson, A. R., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.3966 · Cited by 689
Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression
Sun, X., He, G., Qing, H., Zhou, W., Dobie, F., Cai, F., Staufenbiel, M., Huang, L. E., & Song, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606298103 · Cited by 605 · cited 2×
“…(Carmeliet and Ruiz de Almodovar 2013; Qin et al. 2015; Tarkowski et al. 2002; Vagnucci and Li 2003), VEGF is sequestered by Ab plaques (Yang et al. 2004) and its signaling is inhibited by Ab (Patel et al. 2010), thus reducing its angiogenic property and causing further hypoxia (Sun et al. 2006).”
Hypertension and Cerebrovascular Dysfunction
Iadecola, C., & Davisson, R. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.03.010 · Cited by 557
Probing the biology of Alzheimer’s disease in mice
Ashe, K. H., & Zahs, K. R. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.031 · Cited by 413
Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance
Zhao, Z., Sagare, A. P., Ma, Q., Halliday, M. R., Kong, P., Kisler, K., Winkler, E. A., Ramanathan, A., Kanekiyo, T., Bu, G., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4025 · Cited by 410 · cited 5×
“…activity, is removed from the brain via mechanisms involving the lipoprotein receptor-related protein (LRP)-1 and P-glycoprotein, a mechanism regulated by the serum response factor, myocardin, and phosphatidylcholinebinding clathrin assembly protein (PICALM) (Zhao et al. 2015; Zlokovic 2008).”
InfluentialSOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein
Iadecola, C., Zhang, F., Niwa, K., Eckman, C., Turner, S. K., Fischer, E., Younkin, S., Borchelt, D. R., Hsiao, K. K., & Carlson, G. A. (1999) · Nature Neuroscience · doi:10.1038/5715 · Cited by 399
Hypertension: A Harbinger of Stroke and Dementia
Faraco, G., & Iadecola, C. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01063 · Cited by 367 · cited 3×
“These changes occur early in the course of the disease and are also present in cognitively normal people at genetic risk for AD (Nordberg et al. 2010; Faraco and Iadecola 2013; Iadecola 2013 ).”
Tarkowski, E., Issa, R., Sjögren, M., Wallin, A., Blennow, K., Tarkowski, A., & Kumar, P. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00285-8 · Cited by 360 · cited 1×
“Even though CSF and plasma levels of VEGF are increased in AD patients (Carmeliet and Ruiz de Almodovar 2013; Qin et al. 2015; Tarkowski et al. 2002; Vagnucci and Li 2003), VEGF is sequestered by Ab plaques (Yang et al. 2004) and its signaling is inhibited by Ab (Patel et al. 2010), thus reducing…”
Neurovascular signalling defects in neurodegeneration
Zacchigna, S., Lambrechts, D., & Carmeliet, P. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2336 · Cited by 345 · cited 2×
“Cell Mol Neurobiol (2016) 36:155–165 157 Angiogenesis Endothelial cells, neurons, and glia produce vascular growth factors that provide trophic support for angiogenesis (Zacchigna et al. 2008).”
Park, L., Zhou, P., Pitstick, R., Capone, C., Anrather, J., Norris, E. H., Younkin, L., Younkin, S., Carlson, G., McEwen, B. S., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711568105 · Cited by 332 · cited 12×
“One likely pathway is that ROS inactivate the endogenous vasoactive mediators regulating CBF.”
InfluentialSelf-citationBiron, K. E., Dickstein, D. L., Gopaul, R., & Jefferies, W. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023789 · Cited by 300 · cited 3×
“In AD, VEGF immunoreactivity overlaps with Ab plaques and is found in association with reactive astrocytes, neurons, and blood vessel walls (Biron et al. 2011).”
Weller, R. O., Boche, D., & Nicoll, J. A. R. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0498-z · Cited by 297 · cited 2×
“In addition, alteration of neurovascular function may accelerate Ab accumulation in the brain by slowing its perivascular and transvascular clearance (Iadecola 2013; Weller et al. 2009).”
β-Amyloid, Blood Vessels, and Brain Function
Smith, E. E., & Greenberg, S. M. (2009) · Stroke · doi:10.1161/strokeaha.108.536839 · Cited by 293 · cited 3×
“At the microvascular level, arterioles and capillaries show reduction in density, length, and mean diameters in AD (Bouras et al. 2006; Fischer et al. 1990; Kitaguchi et al. 2007; Smith and Greenberg 2009).”
TRPM2: a multifunctional ion channel for calcium signalling
Sumoza‐Toledo, A., & Penner, R. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2010.201855 · Cited by 290 · cited 2×
“As described above, ADPR is a potent activator of TRPM2 channels leading to increases of intracellular Ca and other cations (Buelow et al. 2008; Sumoza-Toledo and Penner 2011).”
SRF and myocardin regulate LRP-mediated amyloid-β clearance in brain vascular cells
Bell, R. D., Deane, R., Chow, N., Long, X., Sagare, A., Singh, I., Streb, J. W., Guo, H., Rubio, A., Van Nostrand, W., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1819 · Cited by 261 · cited 1×
“…the reduced expression of the BBB transporters LRP-1, P-glycoprotein, and PICALM or the increased expression of Mfsda2 in the brain endothelium promotes vascular Ab accumulation and may worsen the vascular dysfunction (Bell et al. 2009; Deane et al. 2003; Zhao et al. 2015; Ben- Zvi et al. 2014).”
Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease
Meyer, E. P., Ulmann-Schuler, A., Staufenbiel, M., & Krucker, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709788105 · Cited by 260 · cited 1×
“In AD patients and mouse models, these alterations are often associated with distortion and constriction of capillaries (Smith and Greenberg 2009; Kitaguchi et al. 2007; Meyer et al. 2008; Park et al. 2013).”
Blood-brain barrier permeability abnormalities in vascular cognitive impairment
Taheri, S., Gasparovic, C., Huisa, B. N., Adair, J. C., Edmonds, E., Prestopnik, J., Grossetete, M., Shah, N. J., Wills, J., Qualls, C., et al. (2011) · Stroke · doi:10.1161/strokeaha.110.611731 · Cited by 248 · cited 1×
“Furthermore, impairments in Ab clearance through the BBB may also have an impact on the brain amyloid accumulation in AD (Taheri et al. 2011; Zlokovic 2008; Mawuenyega et al. 2010; Roberts et al. 2014).”
Park, L., Anrather, J., Zhou, P., Frys, K., Pitstick, R., Younkin, S., Carlson, G. A., & Iadecola, C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5207-04.2005 · Cited by 244
Self-citationEndothelial influences on cerebrovascular tone
Andresen, J., Shafi, N. I., & Bryan, R. M. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00937.2005 · Cited by 235 · cited 2×
“Cerebral endothelial cells play a critical role in the CBF regulation by producing vasorelaxants, such as NO, bradykinin, prostacyclin, and vasoconstrictors, such as endothelin-1 and thromboxane A2 (Andresen et al. 2006; Faraci 2011; Iadecola 2004, 2013; Katusic and Austin 2014).”
Cerebral Hemodynamics and Vascular Risk Factors: Setting the Stage for Alzheimer's Disease
de la Torre, J. C. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120793 · Cited by 219
Niwa, K., Kazama, K., Younkin, S. G., Carlson, G. A., & Iadecola, C. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0460 · Cited by 218
NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries
Miller, A. A., Drummond, G. R., Schmidt, H. H. H. W., & Sobey, C. G. (2005) · Circulation Research · doi:10.1161/01.res.0000189301.10217.87 · Cited by 211 · cited 2×
“Initially identified in phagocytes , NADPH oxidase is also found in vascular cells and is especially abundant in the brain blood vessels (Drummond et al. 2011; Miller et al. 2005).”
Chow, N., Bell, R. D., Deane, R., Streb, J. W., Chen, J., Brooks, A., Van Nostrand, W., Miano, J. M., & Zlokovic, B. V. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608251104 · Cited by 209 · cited 2×
“rioles associated with reduced resting CBF and reactivity (Chow et al. 2007).”
Protecting against vascular disease in brain
Faraci, F. M. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01310.2010 · Cited by 196 · cited 2×
“Cerebral endothelial cells play a critical role in the CBF regulation by producing vasorelaxants, such as NO, bradykinin, prostacyclin, and vasoconstrictors, such as endothelin-1 and thromboxane A2 (Andresen et al. 2006; Faraci 2011; Iadecola 2004, 2013; Katusic and Austin 2014).”
Niwa, K., Carlson, G. A., & Iadecola, C. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200012000-00005 · Cited by 191 · cited 1×
“Ab promotes ROS production in cerebral endothelial cells and ROS scavengers counteract the effects of Ab on endothelial dysfunction and functional hyperemia (Niwa et al. 2000a, b, 2002).”
VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration
Carmeliet, P., & de Almodovar, C. R. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1283-7 · Cited by 173
Park, L., Wang, G., Zhou, P., Zhou, J., Pitstick, R., Previti, M. L., Younkin, L., Younkin, S. G., Van Nostrand, W. E., Cho, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015413108 · Cited by 156 · cited 2×
“For example, the lack of the innate immunity receptor CD36 or RAGE protects endothelium-dependent responses and neurovascular coupling by attenuating vascular oxidative stress in WT mice treated with Ab and amyloid precursor protein (APP) transgenic mice (Park et al. 2011, 2013).”
Self-citationDede, D. S., Yavuz, B., Yavuz, B. B., Cankurtaran, M., Halil, M., Ulger, Z., Cankurtaran, E. S., Aytemir, K., Kabakci, G., & Ariogul, S. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01378.x · Cited by 142
Staekenborg, S. S., Koedam, E. L. G. E., Henneman, W. J. P., Stokman, P., Barkhof, F., Scheltens, P., & van der Flier, W. M. (2009) · Stroke · doi:10.1161/strokeaha.108.531343 · Cited by 139 · cited 1×
“These alterations in angiogenesis are likely to have a powerful impact in the cerebrovascular alterations found in AD and vascular dementia as well as in the brain atrophy related to these diseases (Savva et al. 2009; Staekenborg et al. 2009).”
Thal, D. R., Capetillo-Zarate, E., Larionov, S., Staufenbiel, M., Zurbruegg, S., & Beckmann, N. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.017 · Cited by 138 · cited 1×
“In AD mouse model, vascular density is reduced in the cortex, hippocampus, and white matter at 7–9 months, a finding often associated with capillary CAA, vessel occlusion, blood flow disturbances, and BBB leakage (Biron et al. 2011; Lee et al. 2005; Paris et al. 2004; Thal et al. 2009).”
Han, B. H., Zhou, M.-L., Johnson, A. W., Singh, I., Liao, F., Vellimana, A. K., Nelson, J. W., Milner, E., Cirrito, J. R., Basak, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414930112 · Cited by 131
Luckhaus, C., Flüß, M. O., Wittsack, H.-J., Grass-Kapanke, B., Jänner, M., Khalili-Amiri, R., Friedrich, W., Supprian, T., Gaebel, W., Mödder, U., et al. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.11.053 · Cited by 88 · cited 1×
“CBF is decreased, and functional hyperemia is reduced in AD patients (Bateman et al. 2006; Hirao et al. 2005; Jagust et al. 1998; Johnson and Albert 2000; Luckhaus et al. 2008; Ruitenberg et al. 2005; Schroeter et al. 2007; Yoshiura et al. 2009).”
Cited by
Involvement of Lipids in Alzheimer’s Disease Pathology and Potential Therapies
Chew, H., Solomon, V. A., & Fonteh, A. N. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00598 · Cited by 353
“Overexpression may lead to dysregulated inflammation and increased oxidative stress, a biomarker of the inflammatory response, and AD (Park et al., 2014; Koizumi et al., 2016).”
BackgroundCoronary Microvascular Dysfunction
Vancheri, F., Longo, G., Vancheri, S., & Henein, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092880 · Cited by 321
Paik, D. T., Tian, L., Williams, I. M., Rhee, S., Zhang, H., Liu, C., Mishra, R., Wu, S. M., Red-Horse, K., & Wu, J. C. (2020) · Circulation · doi:10.1161/circulationaha.119.041433 · Cited by 281
Brain Perivascular Macrophages Initiate the Neurovascular Dysfunction of Alzheimer Aβ Peptides
Park, L., Uekawa, K., Garcia-Bonilla, L., Koizumi, K., Murphy, M., Pistik, R., Younkin, L., Younkin, S., Zhou, P., Carlson, G., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.311054 · Cited by 259
Self-citationMarkers and Biomarkers of Endothelium: When Something Is Rotten in the State
Goncharov, N. V., Nadeev, A. D., Jenkins, R. O., & Avdonin, P. V. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9759735 · Cited by 190
“It was shown that extracellular buildup of amyloid-β (Aβ) in Alzheimer’s disease (AD) impairs endothelial structure and function through activation of the TRPM2, leading to intracellular Ca overload and vasomotor dysfunction [114].”
Background
Metadata
- Authors
- Koizumi, K., Wang, G., & Park, L.
- Venue
- Cellular and Molecular Neurobiology
- Published
- 2015-09-02
- Volume
- 36
- Issue
- 2
- Pages
- 155-165
- ISSN
- 0272-4340 (ISSN-L)
- 1573-6830
- OpenAlex
- W1211803770
- Cited by
- 118
- References
- 49
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.